KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vir Biotechnology (VIR) Other Non Operating Income (2018 - 2025)

Historic Other Non Operating Income for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to -$228000.0.

  • Vir Biotechnology's Other Non Operating Income rose 7446.81% to -$228000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$580000.0, marking a year-over-year increase of 8187.5%. This contributed to the annual value of -$2.2 million for FY2024, which is 7529.75% up from last year.
  • Vir Biotechnology's Other Non Operating Income amounted to -$228000.0 in Q3 2025, which was up 7446.81% from $226000.0 recorded in Q2 2025.
  • In the past 5 years, Vir Biotechnology's Other Non Operating Income ranged from a high of $27.0 million in Q3 2022 and a low of -$26.2 million during Q4 2022
  • Over the past 5 years, Vir Biotechnology's median Other Non Operating Income value was -$228000.0 (recorded in 2025), while the average stood at -$866473.7.
  • Data for Vir Biotechnology's Other Non Operating Income shows a peak YoY increase of 4212812.5% (in 2022) and a maximum YoY decrease of 37400000.0% (in 2022) over the last 5 years.
  • Vir Biotechnology's Other Non Operating Income (Quarter) stood at -$7000.0 in 2021, then tumbled by 374000.0% to -$26.2 million in 2022, then surged by 94.33% to -$1.5 million in 2023, then surged by 65.93% to -$506000.0 in 2024, then surged by 54.94% to -$228000.0 in 2025.
  • Its Other Non Operating Income was -$228000.0 in Q3 2025, compared to $226000.0 in Q2 2025 and -$72000.0 in Q1 2025.